Mitchell Mcgill
Concepts (320)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acetaminophen | 61 | 2023 | 349 | 11.330 |
Why?
| Liver | 44 | 2022 | 1225 | 4.400 |
Why?
| Analgesics, Non-Narcotic | 17 | 2021 | 140 | 3.150 |
Why?
| Drug Overdose | 16 | 2020 | 154 | 2.760 |
Why?
| Hepatocytes | 22 | 2020 | 214 | 2.220 |
Why?
| Liver Failure, Acute | 6 | 2023 | 64 | 1.820 |
Why?
| Alanine Transaminase | 12 | 2023 | 151 | 1.800 |
Why?
| Liver Regeneration | 5 | 2019 | 57 | 1.720 |
Why?
| Oxidative Stress | 15 | 2023 | 958 | 1.680 |
Why?
| Mice, Inbred C57BL | 35 | 2022 | 1999 | 1.600 |
Why?
| Animals | 65 | 2023 | 14385 | 1.570 |
Why?
| Glutathione | 14 | 2023 | 330 | 1.450 |
Why?
| Mitochondria, Liver | 8 | 2016 | 86 | 1.410 |
Why?
| Cochlea | 2 | 2019 | 20 | 1.250 |
Why?
| Mitochondria | 9 | 2020 | 489 | 1.230 |
Why?
| JNK Mitogen-Activated Protein Kinases | 12 | 2015 | 78 | 1.230 |
Why?
| Mice | 38 | 2023 | 6413 | 1.090 |
Why?
| End Stage Liver Disease | 2 | 2023 | 43 | 1.080 |
Why?
| DNA, Mitochondrial | 6 | 2017 | 186 | 1.000 |
Why?
| DNA Fragmentation | 5 | 2016 | 67 | 1.000 |
Why?
| Methamphetamine | 3 | 2022 | 233 | 0.990 |
Why?
| Glutamate Dehydrogenase | 5 | 2021 | 15 | 0.970 |
Why?
| Liver Diseases | 2 | 2023 | 87 | 0.930 |
Why?
| Phosphatidic Acids | 2 | 2019 | 8 | 0.820 |
Why?
| Necrosis | 12 | 2020 | 208 | 0.780 |
Why?
| Antioxidants | 4 | 2023 | 297 | 0.750 |
Why?
| Plant Extracts | 6 | 2022 | 193 | 0.750 |
Why?
| Male | 45 | 2022 | 27334 | 0.730 |
Why?
| Humans | 53 | 2023 | 54284 | 0.730 |
Why?
| Xenobiotics | 2 | 2019 | 27 | 0.710 |
Why?
| Disease Models, Animal | 8 | 2019 | 1639 | 0.690 |
Why?
| Glycerol-3-Phosphate O-Acyltransferase | 1 | 2019 | 5 | 0.690 |
Why?
| ortho-Aminobenzoates | 1 | 2019 | 9 | 0.690 |
Why?
| Liver Cirrhosis | 1 | 2021 | 216 | 0.690 |
Why?
| Pharmaceutical Preparations | 1 | 2019 | 86 | 0.650 |
Why?
| Phosphatidate Phosphatase | 1 | 2018 | 11 | 0.650 |
Why?
| Stilbenes | 2 | 2015 | 65 | 0.650 |
Why?
| Apoptosis | 9 | 2016 | 1300 | 0.650 |
Why?
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2014 | 10 | 0.630 |
Why?
| Cytochrome P-450 Enzyme System | 6 | 2020 | 192 | 0.630 |
Why?
| Sulfonamides | 1 | 2019 | 146 | 0.620 |
Why?
| Drug Delivery Systems | 1 | 2019 | 151 | 0.610 |
Why?
| Acetylcysteine | 3 | 2014 | 118 | 0.600 |
Why?
| Pyridines | 2 | 2015 | 137 | 0.590 |
Why?
| Reactive Oxygen Species | 5 | 2015 | 491 | 0.590 |
Why?
| C-Reactive Protein | 1 | 2018 | 159 | 0.590 |
Why?
| Enzyme Inhibitors | 2 | 2019 | 446 | 0.580 |
Why?
| Paraproteins | 1 | 2016 | 13 | 0.580 |
Why?
| Electron Transport Chain Complex Proteins | 2 | 2017 | 13 | 0.570 |
Why?
| Immunoglobulin M | 1 | 2016 | 65 | 0.560 |
Why?
| Nuclear Proteins | 1 | 2018 | 252 | 0.560 |
Why?
| Creatinine | 1 | 2016 | 169 | 0.560 |
Why?
| Sulfhydryl Reagents | 1 | 2015 | 3 | 0.550 |
Why?
| Ethylmaleimide | 1 | 2015 | 4 | 0.550 |
Why?
| Glutathione Reductase | 1 | 2015 | 15 | 0.550 |
Why?
| Hearing | 1 | 2016 | 61 | 0.540 |
Why?
| Signal Transduction | 6 | 2022 | 1753 | 0.520 |
Why?
| Furosemide | 1 | 2014 | 9 | 0.520 |
Why?
| Cannabidiol | 3 | 2020 | 35 | 0.520 |
Why?
| DNA | 3 | 2022 | 581 | 0.510 |
Why?
| Antidotes | 2 | 2014 | 33 | 0.500 |
Why?
| Argininosuccinate Synthase | 1 | 2014 | 1 | 0.490 |
Why?
| Protein Binding | 8 | 2018 | 736 | 0.460 |
Why?
| Diosgenin | 1 | 2012 | 1 | 0.450 |
Why?
| Carnitine | 1 | 2013 | 86 | 0.450 |
Why?
| Dose-Response Relationship, Drug | 11 | 2019 | 1476 | 0.420 |
Why?
| Rats, Wistar | 3 | 2022 | 237 | 0.420 |
Why?
| Prognosis | 5 | 2023 | 2118 | 0.410 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 142 | 0.400 |
Why?
| Young Adult | 9 | 2021 | 4318 | 0.370 |
Why?
| Critical Illness | 1 | 2013 | 344 | 0.370 |
Why?
| Rats | 5 | 2022 | 3415 | 0.360 |
Why?
| Middle Aged | 14 | 2021 | 13088 | 0.350 |
Why?
| HMGB1 Protein | 3 | 2021 | 17 | 0.350 |
Why?
| Keratin-18 | 3 | 2021 | 15 | 0.350 |
Why?
| Bile Ducts | 2 | 2020 | 53 | 0.350 |
Why?
| Cell Death | 6 | 2020 | 223 | 0.350 |
Why?
| Autophagy | 4 | 2021 | 202 | 0.340 |
Why?
| Female | 20 | 2021 | 28441 | 0.340 |
Why?
| Oxidation-Reduction | 2 | 2023 | 382 | 0.330 |
Why?
| Connexins | 3 | 2016 | 29 | 0.310 |
Why?
| Glutathione Disulfide | 3 | 2016 | 45 | 0.300 |
Why?
| Mice, Knockout | 8 | 2018 | 926 | 0.290 |
Why?
| Amino Acid Chloromethyl Ketones | 2 | 2016 | 17 | 0.280 |
Why?
| Reperfusion Injury | 2 | 2020 | 118 | 0.280 |
Why?
| Kinetics | 2 | 2019 | 692 | 0.270 |
Why?
| Hepatitis | 2 | 2016 | 21 | 0.270 |
Why?
| Adult | 11 | 2021 | 14207 | 0.260 |
Why?
| Cholestasis | 2 | 2015 | 45 | 0.250 |
Why?
| MicroRNAs | 3 | 2020 | 386 | 0.250 |
Why?
| Ischemia | 2 | 2016 | 177 | 0.250 |
Why?
| Time Factors | 7 | 2019 | 3213 | 0.240 |
Why?
| Alanine | 1 | 2023 | 44 | 0.240 |
Why?
| Pyruvic Acid | 1 | 2023 | 24 | 0.240 |
Why?
| Lung | 2 | 2019 | 507 | 0.240 |
Why?
| Models, Biological | 3 | 2019 | 823 | 0.230 |
Why?
| Mitochondrial Proteins | 2 | 2015 | 121 | 0.230 |
Why?
| Antipyretics | 2 | 2013 | 4 | 0.230 |
Why?
| 5-Methylcytosine | 1 | 2022 | 18 | 0.220 |
Why?
| Cannabis | 3 | 2020 | 147 | 0.220 |
Why?
| Cysteine | 2 | 2013 | 62 | 0.220 |
Why?
| Severity of Illness Index | 2 | 2023 | 1084 | 0.220 |
Why?
| DNA Damage | 2 | 2014 | 357 | 0.210 |
Why?
| Amphetamine | 1 | 2022 | 42 | 0.210 |
Why?
| Half-Life | 1 | 2022 | 92 | 0.210 |
Why?
| Phosphorylation | 3 | 2019 | 614 | 0.200 |
Why?
| Dietary Supplements | 2 | 2022 | 449 | 0.200 |
Why?
| Proliferating Cell Nuclear Antigen | 2 | 2019 | 82 | 0.200 |
Why?
| Tandem Mass Spectrometry | 1 | 2022 | 248 | 0.200 |
Why?
| Drug Administration Schedule | 1 | 2021 | 401 | 0.190 |
Why?
| Risk Assessment | 2 | 2023 | 1361 | 0.190 |
Why?
| Adenosylhomocysteinase | 1 | 2020 | 11 | 0.190 |
Why?
| Alcohol Dehydrogenase | 1 | 2020 | 31 | 0.180 |
Why?
| Aldehyde Dehydrogenase | 1 | 2020 | 27 | 0.180 |
Why?
| Granzymes | 1 | 2020 | 13 | 0.180 |
Why?
| Biological Transport, Active | 1 | 2019 | 35 | 0.180 |
Why?
| Hepatic Veno-Occlusive Disease | 1 | 2019 | 10 | 0.180 |
Why?
| Enzyme Activation | 3 | 2014 | 329 | 0.170 |
Why?
| Sulfotransferases | 1 | 2019 | 43 | 0.170 |
Why?
| Bronchoconstriction | 1 | 2019 | 10 | 0.170 |
Why?
| Haptoglobins | 1 | 2018 | 4 | 0.170 |
Why?
| Anti-Obesity Agents | 1 | 2019 | 22 | 0.170 |
Why?
| Systems Biology | 1 | 2019 | 33 | 0.170 |
Why?
| Anemia, Hemolytic | 1 | 2018 | 12 | 0.170 |
Why?
| Hemolysis | 1 | 2018 | 32 | 0.170 |
Why?
| Aged | 5 | 2018 | 10054 | 0.170 |
Why?
| Cell Communication | 1 | 2019 | 72 | 0.170 |
Why?
| Tea | 1 | 2019 | 35 | 0.170 |
Why?
| Carbon Tetrachloride | 1 | 2018 | 20 | 0.170 |
Why?
| Pilot Projects | 1 | 2021 | 808 | 0.170 |
Why?
| Liver Transplantation | 1 | 2020 | 160 | 0.160 |
Why?
| Acetylglucosamine | 1 | 2018 | 8 | 0.160 |
Why?
| Aged, 80 and over | 2 | 2018 | 3431 | 0.160 |
Why?
| Myoglobin | 1 | 2018 | 32 | 0.160 |
Why?
| Anthracenes | 2 | 2014 | 13 | 0.160 |
Why?
| beta Catenin | 1 | 2019 | 102 | 0.160 |
Why?
| N-Acetylglucosaminyltransferases | 1 | 2018 | 19 | 0.160 |
Why?
| Locomotion | 1 | 2019 | 83 | 0.160 |
Why?
| Immune Tolerance | 1 | 2018 | 104 | 0.160 |
Why?
| Cells, Cultured | 7 | 2016 | 1737 | 0.160 |
Why?
| Bronchodilator Agents | 1 | 2019 | 74 | 0.160 |
Why?
| Hep G2 Cells | 3 | 2015 | 46 | 0.160 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2018 | 85 | 0.160 |
Why?
| Glucuronosyltransferase | 1 | 2019 | 157 | 0.150 |
Why?
| Lysosomes | 2 | 2021 | 91 | 0.150 |
Why?
| Cell Line | 3 | 2015 | 1153 | 0.150 |
Why?
| Dexamethasone | 1 | 2020 | 435 | 0.150 |
Why?
| Central Nervous System Stimulants | 1 | 2020 | 255 | 0.150 |
Why?
| Inflammation | 2 | 2020 | 674 | 0.150 |
Why?
| Genetic Variation | 1 | 2018 | 253 | 0.150 |
Why?
| Bacteria | 1 | 2019 | 258 | 0.150 |
Why?
| Caspase Inhibitors | 1 | 2016 | 31 | 0.150 |
Why?
| Prospective Studies | 2 | 2021 | 2604 | 0.150 |
Why?
| False Positive Reactions | 1 | 2016 | 68 | 0.140 |
Why?
| Kidney Function Tests | 1 | 2016 | 59 | 0.140 |
Why?
| Cell Proliferation | 2 | 2019 | 1096 | 0.140 |
Why?
| Gene Expression | 1 | 2019 | 664 | 0.140 |
Why?
| Obesity | 2 | 2018 | 1202 | 0.140 |
Why?
| Case-Control Studies | 3 | 2014 | 1228 | 0.140 |
Why?
| Connexin 43 | 1 | 2016 | 23 | 0.140 |
Why?
| Drug Evaluation, Preclinical | 2 | 2015 | 158 | 0.140 |
Why?
| Proteomics | 3 | 2022 | 343 | 0.140 |
Why?
| Benzyl Alcohol | 1 | 2015 | 3 | 0.140 |
Why?
| Acetanilides | 1 | 2015 | 2 | 0.140 |
Why?
| Analytic Sample Preparation Methods | 1 | 2015 | 4 | 0.140 |
Why?
| Solid Phase Extraction | 1 | 2015 | 12 | 0.140 |
Why?
| Caspases | 1 | 2016 | 146 | 0.140 |
Why?
| Neutrophils | 2 | 2016 | 154 | 0.140 |
Why?
| Taurocholic Acid | 1 | 2015 | 5 | 0.140 |
Why?
| Glycochenodeoxycholic Acid | 1 | 2015 | 7 | 0.140 |
Why?
| Receptors, Proteinase-Activated | 1 | 2015 | 5 | 0.140 |
Why?
| Protein Stability | 1 | 2015 | 44 | 0.140 |
Why?
| Species Specificity | 2 | 2015 | 205 | 0.140 |
Why?
| Antithrombin III | 1 | 2015 | 13 | 0.130 |
Why?
| Prevalence | 1 | 2019 | 1025 | 0.130 |
Why?
| Endonucleases | 1 | 2015 | 19 | 0.130 |
Why?
| Caspase 3 | 2 | 2012 | 135 | 0.130 |
Why?
| Glycodeoxycholic Acid | 1 | 2014 | 7 | 0.130 |
Why?
| Peptide Hydrolases | 1 | 2015 | 67 | 0.130 |
Why?
| Nerve Tissue Proteins | 1 | 2016 | 199 | 0.130 |
Why?
| Blood Proteins | 1 | 2015 | 100 | 0.130 |
Why?
| Body Mass Index | 1 | 2018 | 713 | 0.120 |
Why?
| Predictive Value of Tests | 2 | 2014 | 1048 | 0.120 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2016 | 434 | 0.120 |
Why?
| Reactive Nitrogen Species | 2 | 2011 | 37 | 0.120 |
Why?
| Neutrophil Activation | 1 | 2014 | 10 | 0.120 |
Why?
| Aldehyde Oxidase | 1 | 2013 | 1 | 0.120 |
Why?
| Allopurinol | 1 | 2013 | 8 | 0.120 |
Why?
| Up-Regulation | 1 | 2016 | 508 | 0.120 |
Why?
| Boron Compounds | 1 | 2013 | 18 | 0.120 |
Why?
| ROC Curve | 1 | 2014 | 259 | 0.120 |
Why?
| Gap Junctions | 1 | 2013 | 27 | 0.120 |
Why?
| Gene Expression Regulation | 3 | 2016 | 1062 | 0.120 |
Why?
| Hematopoietic Stem Cells | 1 | 2015 | 215 | 0.120 |
Why?
| Receptors, Formyl Peptide | 1 | 2013 | 3 | 0.110 |
Why?
| Cohort Studies | 1 | 2018 | 1543 | 0.110 |
Why?
| Acute-Phase Reaction | 1 | 2013 | 9 | 0.110 |
Why?
| Blood Platelets | 1 | 2015 | 269 | 0.110 |
Why?
| Phytotherapy | 1 | 2013 | 38 | 0.110 |
Why?
| Cathepsin B | 1 | 2012 | 6 | 0.110 |
Why?
| Purinergic P2X Receptor Antagonists | 1 | 2012 | 4 | 0.110 |
Why?
| Sex Characteristics | 1 | 2014 | 214 | 0.110 |
Why?
| MAP Kinase Kinase 4 | 1 | 2012 | 34 | 0.110 |
Why?
| Chemokines | 1 | 2013 | 96 | 0.110 |
Why?
| Tetrazoles | 1 | 2012 | 43 | 0.110 |
Why?
| Metabolomics | 1 | 2013 | 149 | 0.110 |
Why?
| Glutathione Transferase | 1 | 2013 | 178 | 0.110 |
Why?
| Rats, Inbred F344 | 1 | 2012 | 209 | 0.110 |
Why?
| Microtubule-Associated Proteins | 1 | 2012 | 78 | 0.100 |
Why?
| Models, Theoretical | 1 | 2013 | 184 | 0.100 |
Why?
| Liver Function Tests | 3 | 2019 | 43 | 0.100 |
Why?
| Survival Rate | 1 | 2014 | 951 | 0.100 |
Why?
| NF-E2-Related Factor 2 | 1 | 2012 | 63 | 0.100 |
Why?
| Reproducibility of Results | 1 | 2015 | 1304 | 0.100 |
Why?
| Gentiana | 1 | 2010 | 1 | 0.100 |
Why?
| Kidney | 1 | 2015 | 820 | 0.090 |
Why?
| Ligation | 2 | 2020 | 64 | 0.090 |
Why?
| L-Lactate Dehydrogenase | 2 | 2022 | 79 | 0.090 |
Why?
| Chaperonin 60 | 1 | 2008 | 5 | 0.090 |
Why?
| Mice, Inbred Strains | 2 | 2019 | 198 | 0.080 |
Why?
| Adolescent | 3 | 2016 | 6897 | 0.080 |
Why?
| Computer Simulation | 2 | 2020 | 332 | 0.080 |
Why?
| Rats, Sprague-Dawley | 1 | 2012 | 1663 | 0.080 |
Why?
| Recombinant Fusion Proteins | 1 | 2008 | 206 | 0.080 |
Why?
| Cell Line, Tumor | 1 | 2011 | 1550 | 0.070 |
Why?
| Cytochrome P-450 CYP2E1 | 2 | 2020 | 105 | 0.070 |
Why?
| Primary Cell Culture | 2 | 2015 | 65 | 0.060 |
Why?
| Peroxynitrous Acid | 2 | 2015 | 51 | 0.060 |
Why?
| Cyclosporine | 2 | 2015 | 66 | 0.060 |
Why?
| Cytokines | 2 | 2016 | 676 | 0.060 |
Why?
| Methylation | 1 | 2022 | 130 | 0.050 |
Why?
| Plant Preparations | 1 | 2022 | 38 | 0.050 |
Why?
| Vitamins | 1 | 2022 | 72 | 0.050 |
Why?
| Interleukin-10 | 1 | 2022 | 107 | 0.050 |
Why?
| Ligands | 1 | 2022 | 230 | 0.050 |
Why?
| Chromatography, Liquid | 1 | 2022 | 243 | 0.050 |
Why?
| Cytoprotection | 2 | 2012 | 48 | 0.050 |
Why?
| Taurine | 1 | 2020 | 16 | 0.050 |
Why?
| Biological Assay | 1 | 2021 | 55 | 0.050 |
Why?
| Anti-Inflammatory Agents | 1 | 2022 | 175 | 0.050 |
Why?
| Acyltransferases | 1 | 2020 | 27 | 0.050 |
Why?
| Herb-Drug Interactions | 1 | 2020 | 30 | 0.050 |
Why?
| Interleukin-6 | 1 | 2022 | 315 | 0.050 |
Why?
| Toxicity Tests | 1 | 2020 | 52 | 0.050 |
Why?
| Alkaline Phosphatase | 1 | 2020 | 99 | 0.050 |
Why?
| Monte Carlo Method | 1 | 2020 | 99 | 0.050 |
Why?
| Cytochrome P-450 CYP1A2 | 1 | 2020 | 46 | 0.050 |
Why?
| Glutamine | 1 | 2020 | 168 | 0.040 |
Why?
| Cytochrome P-450 CYP3A | 1 | 2020 | 82 | 0.040 |
Why?
| Respiratory Hypersensitivity | 1 | 2019 | 18 | 0.040 |
Why?
| Carbachol | 1 | 2019 | 33 | 0.040 |
Why?
| Hepatectomy | 1 | 2019 | 33 | 0.040 |
Why?
| Organ Culture Techniques | 1 | 2019 | 53 | 0.040 |
Why?
| Thinness | 1 | 2019 | 57 | 0.040 |
Why?
| Drug Synergism | 1 | 2019 | 171 | 0.040 |
Why?
| Acylation | 1 | 2018 | 7 | 0.040 |
Why?
| Computational Biology | 1 | 2020 | 231 | 0.040 |
Why?
| Albuterol | 1 | 2019 | 58 | 0.040 |
Why?
| Software | 1 | 2020 | 296 | 0.040 |
Why?
| Galactosamine | 1 | 2016 | 3 | 0.040 |
Why?
| Transcriptome | 1 | 2019 | 346 | 0.040 |
Why?
| Microscopy, Fluorescence, Multiphoton | 1 | 2015 | 8 | 0.030 |
Why?
| Injections, Intraperitoneal | 1 | 2015 | 59 | 0.030 |
Why?
| Mice, Inbred BALB C | 1 | 2016 | 368 | 0.030 |
Why?
| Linear Models | 1 | 2016 | 309 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2016 | 199 | 0.030 |
Why?
| Apoptosis Inducing Factor | 1 | 2015 | 6 | 0.030 |
Why?
| Protective Agents | 1 | 2015 | 20 | 0.030 |
Why?
| Immunoenzyme Techniques | 1 | 2015 | 165 | 0.030 |
Why?
| Anesthetics, Local | 1 | 2015 | 74 | 0.030 |
Why?
| Blood Coagulation | 1 | 2015 | 69 | 0.030 |
Why?
| Asthma | 1 | 2019 | 293 | 0.030 |
Why?
| Bile Acids and Salts | 1 | 2015 | 76 | 0.030 |
Why?
| Fatty Acids | 1 | 2015 | 174 | 0.030 |
Why?
| Tyrosine | 1 | 2015 | 137 | 0.030 |
Why?
| NF-kappa B | 1 | 2016 | 335 | 0.030 |
Why?
| Poisoning | 1 | 2014 | 31 | 0.030 |
Why?
| Molecular Targeted Therapy | 1 | 2015 | 128 | 0.030 |
Why?
| Subcellular Fractions | 1 | 2014 | 43 | 0.030 |
Why?
| Disease Susceptibility | 1 | 2014 | 95 | 0.030 |
Why?
| Oxypurinol | 1 | 2013 | 1 | 0.030 |
Why?
| Granulocytes | 1 | 2014 | 26 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 206 | 0.030 |
Why?
| Metallothionein | 1 | 2013 | 11 | 0.030 |
Why?
| Xanthine Oxidase | 1 | 2013 | 16 | 0.030 |
Why?
| tert-Butylhydroperoxide | 1 | 2013 | 6 | 0.030 |
Why?
| Mice, Inbred C3H | 1 | 2013 | 82 | 0.030 |
Why?
| Dimethyl Sulfoxide | 1 | 2013 | 13 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 206 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2019 | 1138 | 0.030 |
Why?
| Blotting, Western | 1 | 2015 | 683 | 0.030 |
Why?
| Ketones | 1 | 2012 | 9 | 0.030 |
Why?
| Cysteine Proteinase Inhibitors | 1 | 2012 | 28 | 0.030 |
Why?
| Dipeptides | 1 | 2012 | 20 | 0.030 |
Why?
| 3-Hydroxybutyric Acid | 1 | 2012 | 4 | 0.030 |
Why?
| Mitochondrial Diseases | 1 | 2014 | 109 | 0.030 |
Why?
| Hepatomegaly | 1 | 2012 | 10 | 0.030 |
Why?
| Sulfates | 1 | 2012 | 27 | 0.030 |
Why?
| Mice, Inbred NOD | 1 | 2012 | 99 | 0.030 |
Why?
| RNA, Messenger | 1 | 2016 | 1202 | 0.030 |
Why?
| Inflammasomes | 1 | 2012 | 60 | 0.030 |
Why?
| Glucuronides | 1 | 2012 | 57 | 0.030 |
Why?
| Oxidants | 1 | 2012 | 64 | 0.030 |
Why?
| Lactic Acid | 1 | 2012 | 90 | 0.030 |
Why?
| Amiodarone | 1 | 2011 | 23 | 0.020 |
Why?
| Triglycerides | 1 | 2012 | 195 | 0.020 |
Why?
| Fatty Liver | 1 | 2012 | 129 | 0.020 |
Why?
| Proteins | 1 | 2014 | 376 | 0.020 |
Why?
| Lipid Peroxidation | 1 | 2011 | 132 | 0.020 |
Why?
| Carrier Proteins | 1 | 2012 | 359 | 0.020 |
Why?
| Cell Survival | 1 | 2012 | 657 | 0.020 |
Why?
| Immunity, Innate | 1 | 2011 | 114 | 0.020 |
Why?
| Chaperonins | 1 | 2008 | 3 | 0.020 |
Why?
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2008 | 3 | 0.020 |
Why?
| Protein Folding | 1 | 2008 | 52 | 0.020 |
Why?
| Protein Conformation | 1 | 2008 | 226 | 0.020 |
Why?
| Binding Sites | 1 | 2008 | 440 | 0.020 |
Why?
| Models, Molecular | 1 | 2008 | 423 | 0.020 |
Why?
| Child | 1 | 2020 | 7341 | 0.020 |
Why?
| United States | 1 | 2016 | 5217 | 0.020 |
Why?
|
|
Mcgill's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|